<DOC>
	<DOCNO>NCT01178827</DOCNO>
	<brief_summary>This study evaluate cerebrospinal fluid level trospium chloride ( Sanctura XRÂ® ) oxybutynin immediate release ( Oxybutynin IR ) memory performance patient overactive bladder age associate memory impairment .</brief_summary>
	<brief_title>Sanctura Muscarinic Receptor Antagonist Resists Transport ( SMART-II ) Trial</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Trospium chloride</mesh_term>
	<mesh_term>Oxybutynin</mesh_term>
	<mesh_term>Mandelic Acids</mesh_term>
	<criteria>Patient present symptom overactive bladder Patient age associate memory impairment No acute unstable medical condition History alcohol substance abuse within 1 year prior study Has donate excess 500mL blood plasma 30 day prior study Has know bleed disorder ( hemophilia ) Previous abdominal bypass surgery obesity</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>